加拿大皇家银行资本市场部近日发布研究报告，将Select Medical Holdings Corporation的股票评级从"跑赢大盘"下调至"行业持平"。该机构同时将其目标股价从每股19美元大幅削减至16.5美元，降幅达到13.2%。
此次评级调整反映出分析师对该公司短期业绩前景的谨慎态度。尽管Select Medical作为专业医疗服务提供商在康复医院和专科门诊领域保持领先地位，但当前医疗行业面临的运营成本压力及政策环境变化可能对其盈利增长构成挑战。
目标价的下调表明分析师重新评估了该公司的估值水平。16.5美元的新目标价较当前股价仍有上行空间，但较此前预期明显收敛，这或许预示着机构投资者对其未来增长节奏持更保守预期。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.